matters /Others Click here to display all results Last updated on 27 August 2022
Company Year 30/09/2021 2021 Reviewed Consolidated Q3 30/06/2021 Unqualified opinion 2021 Reviewed Company Q3 30/06/2021 Unqualified opinion Click here to display all results Last updated on
Company Q1 31/03/2020 Unqualified opinion with an emphasis of matters Click here to display all results Last updated on 27 August 2022
Consolidated Q3 30/09/2021 2021 Reviewed Company Q2 30/06/2021 Unqualified opinion 2021 Reviewed Consolidated Q2 30/06/2021 Unqualified opinion Click here to display all results Last updated on 27
/Others 2021 Reviewed Consolidated Q2 30/06/2021 Unqualified opinion with an emphasis of matters /Others Click here to display all results Last updated on 27 August 2022
Unqualified opinion with an emphasis of matters Click here to display all results Last updated on 27 August 2022
%. The Company would like to clarify significant changes in the Group’s operating results as follows: 1. Revenues from sales and services for the three-month period of 2018 decreased 39.56% compared to the
. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public
quarter of year 2019, the company had net loss 32.18 million Baht or 0.32 Baht per share. In conclusion, the company’s operating results for the first quarter ended March 31,2019 showed the net Loss which
Exchange of Thailand Copy to: The Secretary The Security and Exchange Commission JCK Hospitality Public Company Limited (“Company”) would like to report the consolidated operating performance results for the